Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 3, 2015, Pages 1389-1397

  Tanaka, Takeshi Q ^a   Guiguemde, W Armand ^b   Barnett, David S ^b   Maron, Maxim I ^c   Min, Jaeki ^b   Connelly, Michele C ^b   Suryadevara, Praveen Kumar ^b   Guy, R Kiplin ^b   Williamson, Kim C ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; IMIDAZOLE DERIVATIVE; NAPHTHOQUINONE;

ARTICLE; DRUG RESISTANCE; DRUG SCREENING; DRUG SENSITIVITY; GAMETOCYTE; HUMAN; MALARIA CONTROL; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; CHEMISTRY; DRUG EFFECTS; HEPG2 CELL LINE; PRECLINICAL STUDY; STRUCTURE ACTIVITY RELATION;

ANTIMALARIALS; DRUG EVALUATION, PRECLINICAL; HEP G2 CELLS; HUMANS; IMIDAZOLES; NAPHTHOQUINONES; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84923242905     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01930-13     Document Type: Article

References (43)

1. malERA Consultative Group. 2011. A research agenda for malaria eradication: drugs. PLoS Med 8:e1000402. http://dx.doi.org/10.1371/journal.pmed.1000402.
2. Chen PQ, Li GQ, Guo XB, He KR, Fu YX, Fu LC, Song YZ. 1994. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J (Engl) 107:709-711.
3. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ. 2008. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 7:125. http://dx.doi.org/10.1186/1475-2875-7-125.
4. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F. 2009. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4:e4551. http://dx.doi.org/10.1371/journal.pone.0004551.
5. Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, Jimenez-Diaz MB, Martinez MS, Wilson EB, Tripathi AK, Gut J, Sharlow ER, Bathurst I, El Mazouni F, Fowble JW, Forquer I, McGinley PL, Castro S, Angulo-Barturen I, Ferrer S, Rosenthal PJ, Derisi JL, Sullivan DJ, Lazo JS, Roos DS, Riscoe MK, Phillips MA, Rathod PK, Van Voorhis WC, Avery VM, Guy RK. 2010. Chemical genetics of Plasmodium falciparum. Nature 465:311-315. http://dx.doi.org/10.1038/nature09099.
6. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF. 2010. Thousands of chemical starting points for antimalarial lead identification. Nature 465:305-310. http://dx.doi.org/10.1038/nature09107.
7. Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA. 2011. Imaging of Plasmodium liver stages to drive nextgeneration antimalarial drug discovery. Science 334:1372-1377. http://dx.doi.org/10.1126/science.1211936.
8. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrian F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA. 2008. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A 105:9059-9064. http://dx.doi.org/10.1073/pnas.0802982105.
9. Bowman JD, Merino EF, Brooks CF, Striepen B, Carlier PR, Cassera MB. 2014. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box. Antimicrob Agents Chemother 58:811-819. http://dx.doi.org/10.1128/AAC.01500-13.
10. Sanders NG, Sullivan DJ, Mlambo G, Dimopoulos G, Tripathi AK. 2014. Gametocytocidal screen identifies novel chemical classes with Plasmodium falciparum transmission blocking activity. PLoS One 9:e105817. http://dx.doi.org/10.1371/journal.pone.0105817.
11. Duffy S, Avery VM. 2013. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J 12:408. http://dx.doi.org/10.1186/1475-2875-12-408.
12. Lucantoni L, Duffy S, Adjalley SH, Fidock DA, Avery VM. 2013. Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob Agents Chemother 57:6050-6062. http://dx.doi.org/10.1128/AAC.00870-13.
13. Ruecker A, Mathias DK, Straschil U, Churcher TS, Dinglasan RR, Leroy D, Sinden RE, Delves MJ. 2014. A male and female gametocyte functional viability assay to identify biologically relevant malaria transmissionblocking drugs. Antimicrob Agents Chemother 58:7292-7302. http://dx.doi.org/10.1128/AAC.03666-14.
14. Williamson KC. 2008. New antimalarials targeting both asexual and ga-metocyte stages. Drugs Future 33:1033-1040. http://dx.doi.org/10.1358/dof.2008.33.12.1287737.
15. Dechy-Cabaret O, Benoit-Vical F. 2012. Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate. J Med Chem 55:10328-10344. http://dx.doi.org/10.1021/jm3005898.
16. Alano P, Carter R. 1990. Sexual differentiation in malaria parasites. Annu Rev Microbiol 44:429-449. http://dx.doi.org/10.1146/annurev.mi.44.100190.002241.
17. Butcher GA. 1997. Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 27:975-987. http://dx.doi.org/10.1016/S0020-7519(97)00079-9.
18. Czesny B, Goshu S, Cook JL, Williamson KC. 2009. The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity. Antimicrob Agents Chemother 53:4080-4085. http://dx.doi.org/10.1128/AAC.00088-09.
19. Lisk G, Kang M, Cohn JV, Desai SA. 2006. Specific inhibition of the plasmodial surface anion channel by dantrolene. Eukaryot Cell 5:1882-1893. http://dx.doi.org/10.1128/EC.00212-06.
20. Go ML, Liu M, Wilairat P, Rosenthal PJ, Saliba KJ, Kirk K. 2004. Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes. Antimicrob Agents Chemother 48:3241-3245. http://dx.doi.org/10.1128/AAC.48.9.3241-3245.2004.
21. Saul A, Graves P, Edser L. 1990. Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol. Int J Parasitol 20:1095-1097. http://dx.doi.org/10.1016/0020-7519(90)90056-S.
22. Lisk G, Pain M, Sellers M, Gurnev PA, Pillai AD, Bezrukov SM, Desai SA. 2010. Altered plasmodial surface anion channel activity and in vitro resistance to permeating antimalarial compounds. Biochim Biophys Acta 1798:1679-1688. http://dx.doi.org/10.1016/j.bbamem.2010.04.013.
23. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ. 2004. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 48:1329-1334. http://dx.doi.org/10.1128/AAC.48.4.1329-1334.2004.
24. Yeh E, DeRisi JL. 2011. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol 9:e1001138. http://dx.doi.org/10.1371/journal.pbio.1001138.
25. Gantt SM, Myung JM, Briones MR, Li WD, Corey EJ, Omura S, Nussenzweig V, Sinnis P. 1998. Proteasome inhibitors block development of Plasmodium spp. Antimicrob Agents Chemother 42:2731-2738.
26. Lindenthal C, Weich N, Chia YS, Heussler V, Klinkert MQ. 2005. The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites. Parasitology 131(Pt 1):37-44. http://dx.doi.org/10.1017/S003118200500747X.
27. Reynolds JM, El Bissati K, Brandenburg J, Gunzl A, Mamoun CB. 2007. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol 7:13. http://dx.doi.org/10.1186/1472-6904-7-13.
28. Tanaka TQ, Williamson KC. 2011. A malaria gametocytocidal assay using oxidoreduction indicator, alamar Blue. Mol Biochem Parasitol 177: 160-163. http://dx.doi.org/10.1016/j.molbiopara.2011.02.005.
29. Hobbs CV, Tanaka TQ, Muratova O, Van Vliet J, Borkowsky W, Williamson KC, Duffy PE. 2013. HIV treatments have malaria gametocyte killing and transmission blocking activity. J Infect Dis 208:139-148. http://dx.doi.org/10.1093/infdis/jit132.
30. Guiguemde WA, Shelat AA, Garcia-Bustos JF, Diagana TT, Gamo FJ, Guy RK. 2012. Global phenotypic screening for antimalarials. Chem Biol 19:116-129. http://dx.doi.org/10.1016/j.chembiol.2012.01.004.
31. Trager W, Jensen JB. 1976. Human malaria parasites in continuous culture. Science 193:673-675. http://dx.doi.org/10.1126/science.781840.
32. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. 2004. Simple and inexpensive fluorescence-based technique for highthroughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803-1806. http://dx.doi.org/10.1128/AAC.48.5.1803-1806.2004.
33. R Development Core Team. 2011. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
34. Ritz C, Streibig JC. 2005. Bioassay analysis using R. J Stat Softw 12(5). http://www.jstatsoft.org/v12/i05/paper.
35. Zhang G, Manaca MN, McNamara-Smith M, Mayor A, Nhabomba A, Berthoud TK, Khoo SK, Wiertsema S, Aguilar R, Barbosa A, Quinto L, Candelaria P, Schultz EN, Hayden CM, Goldblatt J, Guinovart C, Alonso PL, Lesouef PN, Dobano C. 2012. Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun 80:2316-2322. http://dx.doi.org/10.1128/IAI.00261-12.
36. Sun W, Tanaka TQ, Magle CT, Huang W, Southall N, Huang R, Dehdashti SJ, McKew JC, Williamson KC, Zheng W. 2014. Chemical signatures and new drug targets for gametocytocidal drug development. Sci Rep 4:3743. http://dx.doi.org/10.1038/srep03743.
37. Silvestrini F, Lasonder E, Olivieri A, Camarda G, van Schaijk B, Sanchez M, Younis Younis S, Sauerwein R, Alano P. 2010. Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics 9:1437-1448. http://dx.doi.org/10.1074/mcp.M900479-MCP200.
38. Lasonder E, Ishihama Y, Andersen JS, Vermunt AMW, Pain A, Sauerwein RW, Eling WMC, Hall N, Waters AP, Stunnenberg HG, Mann M. 2002. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419:537-542. http://dx.doi.org/10.1038/nature01111.
39. Young JA, Fivelman QL, Blair PL, de la Vega P, Le Roch KG, Zhou Y, Carucci DJ, Baker DA, Winzeler EA. 2005. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontologybased pattern identification. Mol Biochem Parasitol 143:67-79. http://dx.doi.org/10.1016/j.molbiopara.2005.05.007.
40. Eksi S, Haile Y, Furuya T, Ma L, Su X, Williamson KC. 2005. Identification of a subtelomeric gene family expressed during the asexual-sexual stage transition in Plasmodium falciparum. Mol Biochem Parasitol 143: 90-99. http://dx.doi.org/10.1016/j.molbiopara.2005.05.010.
41. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De La Vega P, Holder AA, Batalov S, Carucci DJ, Winzeler EA. 2003. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301:1503-1508. http://dx.doi.org/10.1126/science.1087025.
42. Mair GR, Braks JA, Garver LS, Wiegant JC, Hall N, Dirks RW, Khan SM, Dimopoulos G, Janse CJ, Waters AP. 2006. Regulation of sexual development of Plasmodium by translational repression. Science 313: 667-669. http://dx.doi.org/10.1126/science.1125129.
43. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ. 2002. A proteomic view of the Plasmodium falciparum life cycle. Nature 419:520-526. http://dx.doi.org/10.1038/nature01107.